I don't think it's self-evident. Obviously, the better certain genetic combinations, the worse others have to be, but we don't have all the underlying info -- and we do know that the majority of patients should meaningfully benefit. I don't think the S1R WT + COL24A1 combo fully occupies that space, or at least I haven't seen it demonstrated.
Market Data 
Markets 
